Crow Point Partners »

Intercept Pharmaceuticals In shares owned by Crow Point Partners

Quarter-by-quarter ownership of Intercept Pharmaceuticals In shares owned by Crow Point Partners from 13F filings

Historical chart of Crow Point Partners investment in Intercept Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Intercept Pharmaceuticals In held by Crow Point Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intercept Pharmaceuticals In by Crow Point Partners

Quarter filed Position value Share count Share price at filing
2019-12-31 $222k 1.8k 123.33
2019-03-31 $681k 6.1k 111.94

More positions owned by Crow Point Partners

iShares S&P MidCap 400 Index (IJH)
Spdr Bloomberg Barclays High Yield Bond Etf etf (JNK)
iShares S&P Natl AMTFr Mncpl Bd (MUB)
iShares Barclays 20+ Yr Treas.Bond (TLT)
iShares Lehman Aggregate Bond (AGG)
iShares MSCI Netherlands Investable (EWN)
Vaneck Vectors J.p. Morgan Em Local Currency Bond Etf etf (EMLC)
Ishares Inc emrg mrk lc bd (LEMB)
Royce Value Trust (RVT)
Spdr S&p 500 Etf (SPY)
Ishares Tr core msci pac (IPAC)
Tesla Motors (TSLA)
iShares MSCI Germany Index Fund (EWG)
iShares Russell 2000 Growth Index (IWO)
Eaton Vance Limited Duration Income Fund (EVV)

View all positions for Crow Point Partners